
Neladalkib received accelerated approval for adults with advanced ALK-positive NSCLC after specified prior therapies, supported by durable responses in the ALKOVE-1 trial.
In the fourth episode of Coffee With Suzy, we listened back to some of the best moments from the series so far.
In the fourth episode of Coffee With Suzy, we listened back to some of the best moments from the series so far.






